small molecule

YONSA

ABIRATERONE ACETATE

Loss of exclusivityMay 2034latest FDA-listed patent expiry
CompanySUN PHARMACEUTICAL INDUSTRIES LTD

Drug detail

Brand nameYONSA
Active ingredientABIRATERONE ACETATE
Strength125MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2018
Marketing statusRX

Listed patents

PatentExpiresType
10292990May 2034use U-2535
9889144March 2034product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

YONSA patent cliff — loss of exclusivity May 2034 | CliffBio